In vitro release of cisplatin from sol-gel processed porous silica xerogels

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 11, Issue 6, 2004, Pages 341-344

  Czarnobaj, K ^a   Lukasiak J ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cisplatin; Dynamics of Release; Silica Xerogels; Sol Gel Method

Indexed keywords

CISPLATIN; SILICON DIOXIDE;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; GEL; IN VITRO STUDY; METHODOLOGY; POROSITY; PRIORITY JOURNAL; XEROGEL;

CISPLATIN; PHASE TRANSITION; POROSITY; SILICON DIOXIDE;

EID: 9644260648     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/10717540490507451     Document Type: Article

References (7)

1. Ahola, M. S., Sailynoja, E. S., Raitavuo, M. H., Vaahtio, M. M., Salonen, J. I., and Yli-Urpo A. U. 2001. In vitro release of heparin from silica xerogel. Biomaterials 22:2163-2170.
2. Buckley, A. M., and Greenblatt, M. 1994. The sol-gel preparation of silica gels. J. Chem. Educ. 71:599-602.
3. Klein, L. C. 1993. Sol-gel optical materials. Annu. Rev. Mater. Sci. 23:437-452.
4. Livage, J., and Sanchez, C. 1994. Sol-gel chemistry. J. Non-Cryst. Solids 45:11-19.
5. Nguyen, D. T., Smit, M., Dunn, B., and Zink, J. I. 2002. Stabilization of creatine kinase encapsulated in silicate sol-gel materials and unusual temperature effects on its activity. Chem. Mater. 14:4300-4306.
6. Radin, S., Falaize, S., Lee, M. H., and Ducheyne, P. 2002. In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials. Biomaterials 23:3113-3122.
7. Schmidt, H. 1988. Chemistry of material preparation by the sol-gel process. J. Non-Cryst. Solids 100:51-64.